Investigating hormone differences in cardiac surgery patients
Official title: Differences in Plasma Concentration of RAAS-axis Hormones in Patients Undergoing Cardiac Surgery With or Without Cardiopulmonary Bypass
Run by Universität Münster · NCT05833828 · Data updated 2026-11-12
This study looks at hormone levels in patients having different types of heart surgery to see how these levels might affect complications like low blood pressure during the procedure.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Universität Münster Academic / other |
| Locations | 2 sites (Berlin and 1 other locations) |
| Status | Recruiting |
| Started | August 24, 2023 |
| Main results expected | May 2025 |
| Study ends | August 2025 |
| Registry record updated | December 12, 2024 |
| Trial ID | NCT05833828 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adult patients scheduled for on- or off-pump coronary artery bypass graft surgery.
✕Probably not a fit
Patients undergoing emergency surgery for acute coronary syndrome or those with severe lung disease may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study examines the differences in plasma hormone concentrations of the renin-angiotensin-aldosterone system (RAAS) between patients undergoing on-pump versus off-pump cardiac surgery. It aims to understand how cardiopulmonary bypass may influence the incidence of vasoplegia or vasoplegic shock, a serious complication during cardiac procedures. By analyzing hormone levels, the study seeks to clarify the role of pulmonary circulation in regulating vascular tension and blood pressure during surgery.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for preventing vasoplegia in cardiac surgery patients.
How similar studies have gone: While the specific approach of this study is novel, previous studies have indicated the importance of RAAS in cardiovascular complications, suggesting potential for meaningful insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. adult patients undergoing on- or off-pump coronary artery bypass graft surgery 2. written informed consent Exclusion Criteria: 1. emergency surgery in the context of acute coronary syndrome 2. ACE-inhibitor or Angiotensin 1 (AT1)-receptor-blocker intake that was not paused on the day of surgery 3. Chronic kidney disease with estimated glomerular filtration rate (eGFR)\<30ml/min/1.73m² 4. Severe structural lung disease (asbestosis, silicosis, severe sarcoidosis, tuberculosis, severe emphysema, chronic obstructive pulmonary disease (COPD) Gold 3-4, lung fibrosis) 5. Chronic pulmonary hypertension 6. Pregnancy or breastfeeding 7. Persons with any kind of dependency on the investigator or employed by the institution responsible or investigator 8. Persons held in an institution by legal or official order
Where it's running
-
Deutsches Herzzentrum der Charité
Berlin, Germany Recruiting -
University Hospital Münster; Department of Anesthesiology, Intensive Care Medicine and Pain Medicine
Münster, Germany Recruiting
Study contacts
- Study coordinator: Alexander Zarbock, MD
- Email: aki@anit.uni-muenster.de
- Phone: +492518347255
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Femoral versus radial arterial pressure monitoring during cardiac surgery
This trial tests whether femoral arterial catheters give more accurate continuous blood pressure readings than radial catheters in adults undergoing cardiac surgery with cardiopulmonary bypass.
-
Angiotensin II to reduce kidney injury after heart surgery
This trial tests whether angiotensin II, used as the primary blood-pressure medicine instead of norepinephrine after cardiac surgery with cardiopulmonary bypass, can lower the chance of moderate or severe acute kidney injury in adults at higher risk.
-
Examining endothelial cells in inflammatory conditions
This study looks at how certain cells in the blood change in people with sepsis or after major surgery to see if these changes can help us understand inflammation better.
-
Using midodrine to reduce IV vasopressor use in ICU patients
This study is testing if an oral medication called midodrine can help ICU patients with low blood pressure avoid using IV medications.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.